The Collaborative Ocular Melanoma Study - 21/08/11
Doi : 10.1016/j.ohc.2004.11.004
Arun D. Singh, MD a, ⁎ 
, Tero Kivelä, MD, FEBO b
, Tero Kivelä, MD, FEBO b a Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
b Department of Ophthalmology, Helsinki University Central Hospital, Haartmaninkatu 4 C, PL 220, FIN-00029 HUS, Helsinki, Finland
*Corresponding author
Résumé |
This review provides a summary of the main objectives, significant design features, and major findings and achievements of the Collaborative Ocular Melanoma Study (COMS). It has been written by two ophthalmic oncologists who were not part of the COMS study group; therefore, it represents an extramural view of the trial to supplement summaries published by the COMS investigators. Because the randomized design of the COMS was unique, no attempt is made to make any comparison with the results of previous noncontrolled studies.
Le texte complet de cet article est disponible en PDF.Plan
© 2005
Elsevier Inc. Tous droits réservés.
Vol 18 - N° 1
P. 129-142 - mars 2005 Retour au numéro
Article précédent
- Uveal Melanoma: Resection Techniques
- Bertil Damato, Andrew G. Jones
- Metastatic Uveal Melanoma
- Arun D. Singh, Ernest C. Borden
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?